These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11268233)

  • 1. Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference.
    Cohen JS
    Arch Intern Med; 2001 Mar; 161(6):880-5. PubMed ID: 11268233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events.
    Cohen JS
    Arch Intern Med; 2001 Apr; 161(7):957-64. PubMed ID: 11295958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepant antihypertensive dose recommendations.
    Milic M; Ziegler MG
    Clin Exp Hypertens; 2006 Feb; 28(2):171-80. PubMed ID: 16546842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
    Cheng JW; Kalis MM; Feifer S
    Pharmacotherapy; 2001 Jul; 21(7):828-41. PubMed ID: 11444579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicaid prescriber compliance with Joint National Committee VI Hypertension Treatment Guidelines.
    Clause SL; Hamilton RA
    Ann Pharmacother; 2002 Oct; 36(10):1505-11. PubMed ID: 12243597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.
    Hyman DJ; Pavlik VN
    Arch Intern Med; 2000 Aug 14-28; 160(15):2281-6. PubMed ID: 10927724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will better-tolerated antihypertensive agents improve blood pressure control? JNC VI revisited.
    Black HR
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):225S-230S. PubMed ID: 10619575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive Drug Therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year.
    Alderman MH; Madhavan S; Cohen H
    Am J Hypertens; 1996 May; 9(5):413-8. PubMed ID: 8735170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy.
    Ambrosioni E; Leonetti G; Pessina AC; Rappelli A; Trimarco B; Zanchetti A
    J Hypertens; 2000 Nov; 18(11):1691-9. PubMed ID: 11081785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension.
    Xu KT; Moloney M; Phillips S
    Am J Manag Care; 2003 Aug; 9(8):529-36. PubMed ID: 12921230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension.
    Pedone C; Lapane KL
    BMC Public Health; 2003 Jul; 3():24. PubMed ID: 12873353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial treatment of hypertension and adherence to therapy in general practice in Italy.
    Poluzzi E; Strahinja P; Vargiu A; Chiabrando G; Silvani MC; Motola D; Sangiorgi Cellini G; Vaccheri A; De Ponti F; Montanaro N
    Eur J Clin Pharmacol; 2005 Sep; 61(8):603-9. PubMed ID: 16082539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of JNC-VI guidelines on treatment recommendations in the US population.
    Muntner P; He J; Roccella EJ; Whelton PK
    Hypertension; 2002 Apr; 39(4):897-902. PubMed ID: 11967246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New guidelines of the Joint National Committee (USA) on Prevention, Diagnosis and Management of Hypertension. From JNC VI to JNC VII].
    Britov AN; Bystrova MM
    Kardiologiia; 2003; 43(11):93-7. PubMed ID: 14671565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
    Elliott WJ; Weir DR; Black HR
    Arch Intern Med; 2000 May; 160(9):1277-83. PubMed ID: 10809030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gap between evidence and physicians' knowledge and practice regarding hypertension and its drug treatment: a survey in a Chinese city.
    Wang WZ; Tang JL; Hu YH; An JG; Wang YL; Ren ZH; Zhang H; Griffiths S
    Chin Med J (Engl); 2011 Apr; 124(8):1235-41. PubMed ID: 21543003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to use calcium antagonists in hypertension: putting the JNC-VI guidelines into practice. Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure.
    Singh V; Christiana J; Frishman WH
    Drugs; 1999 Oct; 58(4):579-87. PubMed ID: 10551431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment: Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines.
    Manley HJ; Mangum S; Dugan DJ
    Ann Pharmacother; 2002 Dec; 36(12):1975-6; author reply 1976. PubMed ID: 12452768
    [No Abstract]   [Full Text] [Related]  

  • 19. Fixed-dose triple-combination treatments in the management of hypertension.
    Ram CV
    Manag Care; 2013 Dec; 22(12):45-55. PubMed ID: 24555265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.